AUA 2012 - The urodynamic safety of mirabegron based on a phase II bladder outlet obstruction (BOO) clinical trial - Special Report

ATLANTA, GA USA (UroToday) - In his podium presentation, Victor Nitti, MD, NYU Langone Medical Center, reported on the urodynamic safety of mirabegron based on a phase II bladder outlet obstruction (BOO) clinical trial (Abstract 1869).

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
Tags:
Comments (0)
Only registered users can write comments!